Suspension of trading

Redx Pharma Ltd

Stocks

Market Closed - Deutsche Boerse AG 09:29:02 2024-04-30 EDT			5-day change	1st Jan Change
0.1670 ^EUR	+67.00%		-.--%	-

08-14	Redx Pharma Ltd, Skye Bioscience, Inc. - M&A Call
03-10	Redx Pharma Ltd.'s RXC008 Receives US FDA Fast Track Designation	CI

Published on 08/14/2026 at 03:20 pm EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, and welcome to Skye and Redx's definitive transaction agreement and financing presentation. Speaking on today's presentation will be

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Full unlimited browsing across the entire site

Access to all the news and all the data

Access to US, EUROPE AND ASIA Portfolios

Zero Ads for a completely uninterrupted reading experience

Pro Tools: Expert insights, Expert Screeners, historical financial data and reports, thematic lists, transcripts...

08-14	Redx Pharma Ltd, Skye Bioscience, Inc. - M&A Call
03-10	Redx Pharma Ltd.'s RXC008 Receives US FDA Fast Track Designation	CI
01-07	Redx Pharma Limited Announces US FDA Loses Partial Clinical Hold on Zelasudil	CI
25-09-22	Redx to Present New Data for Zelasudil for the Treatment of Idiopathic Pulmonary Fibrosis at ERS	CI
25-05-06	Redx Pharma Announces the Presentation of Additional Results from an RXC008 Phase 1 Clinical Trial	CI
25-02-24	Redx Pharma Limited Announces Presentation of Positive Phase 1 Results from Clinical Trial with RXC008	CI
25-01-11	Redx Pharma Plc Reports Earnings Results for the Full Year Ended September 30, 2024	CI
25-01-11	Redx Pharma Plc Auditor Raises 'Going Concern' Doubt	CI
24-06-28	Redx Pharma Plc Reports Encouraging Zamaporvint Phase 2 Combination Data in MSS mCRC at ESMO GI Congress	CI
24-06-20	Redx to Present Zamaporvint Phase2 Data At Esmo Gi	CI
24-06-17	Redx to Present Preclinical Data on RXC008 in an Oral Presentation at ECM Congress	CI
24-05-15	Redx Pharma plc Appoints Claire Catherinet as Director	CI
24-05-14	Redx Pharma plc Announces the Termination of Dr Joseph Anderson as Director	CI
24-02-15	Redx Pharma Plc Auditor Raises 'Going Concern' Doubt	CI

Duration

Period

Sector